A method of diagnosing attention deficient-hyperactivity disorder (ADHD) in a human patient by assessing the level of dopamine transporter in at least one region of the patient's central nervous system, where an elevated level of dopamine transporter in the patient is indicative of ADHD. In embodiments of the invention, assessment of dopamine transporter levels includes assessing binding of a dopamine transporter ligand to the dopamine transporters using PET or SPECT.

 
Web www.patentalert.com

< Raspberry amido amines and betaines as a delivery system for natural antioxidants

< Antimicrobial polyester-containing articles and process for their preparation

> Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production

> Physiological tissue repair and functional organ regeneration by cultivation of regenerative stem cells in vivo and in situ

~ 00277